Artificial pancreas would reduce need for self-care by diabetics, improve insulin delivery

Cambridge-Universtiy-artificial-pancreas-insulin-pump-diabetes-bloodd-EDIWeekly

Type 1 diabetes sufferers face peculiarly onerous daily demands to maintain their health. They must frequently monitor their blood glucose levels by taking a sample of their blood, and must be constantly aware of day-to-day and within-day variability in those levels, responding by adjusting their insulin delivery. This imposes a “significant psychological burden” and can adversely affect the diabetic’s quality of life, according to researchers at Cambridge University in the UK. At present, diabetics have few alternatives, other than pancreas transplantation. But the development of an “artificial pancreas,” really a closed-loop system consisting of an algorithm-controlled insulin pump that continuously and automatically adjusts the amount of insulin entering the patient’s body, is about to change all of that.

No longer will the diabetic have to monitor his own blood sugar levels several times a day and administer insulin separately. By joining the two actions together in a closed loop, Dr. Roman Hovorka and Dr. Hood Thabit of Cambridge University say they can give diabetics “time off” from their diabetes management, relieving them of the constant concern about becoming either hyperglycaemic (too much blood sugar) or the opposite, hypoglycaemic. Their artificial pancreas reduces the burden of self-care while improving glucose control.

The average diabetic’s insulin requirement varies by 20 per cent during waking hours and 30 per cent at night, but the variability can be even greater depending on diet, exercise and other factors. Unlike conventional insulin pumps, a closed-loop system like this one combines real-time sensors to measure glucose levels with autonomous delivery of insulin as needed. In the Cambridge researchers’ prototype system, the control algorithm runs on a mobile phone. The other components are the continuous glucose monitor and receiver, and the insulin pump.

Responding to day-to-day and within-day glucose variability is the key advantage that adaptive closed-loop systems have over conventional insulin therapies. By autonomously and continually modulating insulin delivery in a glucose-responsive fashion, closed-loop systems deliver insulin to minimise hyper- and hypoglycaemic excursions. Adaptive features of the control algorithms individualise the closed-loop system to particular physiology and lifestyle patterns.

Cambridge-Universtiy-artificial-pancreas-insulin-pump-diabetes-EDIWeekly
A prototype closed-loop system comprising continuous glucose monitor (CGM) sensor and receiver, insulin pump and mobile phone running a control algorithm.

The closed loop device also eliminates the need for the major surgery of a pancreatic transplant, and the subsequent need for immunosuppressant drugs.

The authors report that clinical trials have been carried out in various settings, including controlled laboratory conditions, diabetes camps, and outpatient settings. Trials have shown “as good or better” glucose control than existing technologies. Trials are ongoing, and more studies are planned for both adults and children. Home studies are the “final benchmark” testing environment, and unsupervised free-living home studies have been performed with good results, the researchers say.

At least $200 million has gone into the effort to develop the artificial pancreas over the past decade. The device could receive approval from the US Food and Drug Administration as early as 2017 and could be on the market by 2018.

Did you miss this?

Other Popular Stories

  • Could the Future of Energy be Entirely Renewable?
  • Shed a tear for science? University researchers in Ireland harvest electricity from tears
  • NASA Keeping an Eye on Tesla Roadster
  • Largest biomass power plant in NA set to open in Atikokan
  • Agreement between western provinces smooths way for pipelines
  • Oil train disaster plays to the pro-pipeline position
  • World's first 3D printed auto manufacturing platform
  • Ontario and Saskatchewan criticizes the Federal Canadian Minerals and Metals Plan in a joint official statement
  • Space-based solar power beamed to earth may be the future of green power
  • Montreal firm to build flight simulators for US Navy
  • Has the time come for irradiated beef in Canada?
  • Pembina to build $350 million diluent hub
  • Manufacturing recovers ground in January: GDP up 0.2 per cent
  • Bombardier CS100 certified by Transport Canada
  • Swiss tech does the impossible, creates white solar panels
  • Blue Origin rocket engines to be built in Alabama, employing up to 350
  • Canada's economy grew in Q4, manufacturing up in December
  • Toronto an ideal location for Amazon HQ 2: If Amazon needs to hire tech employees, GTA and Canada has the edge
  • Forest vertical cities in China: first forest city under construction covered in 1 million plants; produce 900 tons oxygen daily
  • Airline debacle highlights need for businesses to be tech smart
Scroll to Top